Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects

NCT06688123 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: SHR-3167
DRUG: SHR-3167
DRUG: Insulin glargine

Sponsor

Jiangsu HengRui Medicine Co., Ltd.